4Plant PK,Owen,Elliott MW. Early use of non. invasive venti- lation for acute exacerbations of chronic obstructive pulmonary disease on gener respiratory wards amuhicentre randomized controlled trail[J]. Lancet,2000,355(9219): 1930-1934.
5Huang KJ, Wang H, Xie WZ. Investigation of the effect of tanshinone IIA on nitric oxide production in human vascular endothelial cells by fluorescence imaging[J]. J Spectrochimica Acta Part A, 2007,68(5) :1180-1186.
6CharlsonME, PompeiP, AlesKL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation[J]. J Chronic Dis, 1987, 40(5): 373–383.
7HallWH, RamachandranR, NarayanS, et al. An electronic application for rapidly calculating Charlson comorbidity score[J]. BMC Cancer, 2004, 4: 94. DOI: 10.1186/1471–2407–4–94.
8NgAC, ChowV, YongAS, et al. Prognostic impact of the Charlson comorbidity index on mortality following acute pulmonary embolism[J]. Respiration, 2013, 85(5): 408–416. DOI: 10.1159/000342024.
9GoldhaberSZ, VisaniL, De RosaM. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)[J]. Lancet, 1999, 353(9162): 1386–1389. DOI: http://dx.doi.org/10.1016/S0140–6736(98)07534–5.
10LaporteS, MismettiP, DecoususH, et al. Clinical predictors for fatal pulmonary embolism in 15 520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry[J]. Circulation, 2008, 117(13): 1711–1716. DOI: 10.1161/CIRCULATIONAHA.107.726232.
